SSA
SPHS

Schonfeld Strategic Advisors’s Sophiris Bio, Inc. SPHS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,883
Closed -$45K – 634
2016
Q2 		$45K Buy
+20,883
New +$28.8K 0.01% 416

Other funds holding SPHS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Schonfeld Strategic Advisors's SPHS Position: Q3 2016 in Review

Schonfeld Strategic Advisors sold out of Sophiris Bio, Inc. (SPHS) in Q3 2016, closing a stake of 20,883 shares — an estimated $45K sold.

Schonfeld Strategic Advisors first reported a position in SPHS in Q2 2016 and held it in 1 quarter. The position peaked at $45K in Q2 2016. 29 funds tracked by Wall St. Rank hold SPHS as of Q3 2016.

  • Schonfeld Strategic Advisors reported no remaining Sophiris Bio, Inc. position as of Q3 2016 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 20,883 Sophiris Bio, Inc. shares in Q3 2016, an estimated $45K.
  • Schonfeld Strategic Advisors first reported a position in Sophiris Bio, Inc. in Q2 2016 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Sophiris Bio, Inc. position peaked at $45K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2016.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.